Conference abstract · 6 Oct 2025
Conference abstractPublished 11 Aug 2016
Drug measurements at the pharmacological target site for individualized pediatric cancer treatment
University of California, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Cancer drug resistance is a consequence of a complex, multidimensional interplay between tumor, its environment and the host. Drugs are often assumed to distribute relatively homogeneously from plasma to tumor tissues. However, distribution of drug in tumors is highly variable and may not correlate with dose or plasma concentrations. Solid tumors are characterized by a complex and unique microenvironment that consists of infiltrating immune cells, low pH, dense interstitial matrix, high interstitial pressure, and abnormal blood and lymphatic vascular structures. Overexpression of drug efflux transporters such as P-glycoprotein (MDR1/ABCB1), breast cancer resistance protein (BCRP/ABCG2), and transporters of the multidrug resistance-associated protein subfamily (MRP/ABCC) may also limit drug penetration in cancer cells or other (off) target cells. Variability in these factors among cancer types may be a contributing factor why translation from adults to pediatric patients often fails. Until recently, assessment of spatial drug distribution in cancer cells or other target cells and clinical implementation of these data was limited by technical challenges. New technologies such mass spectrometric and radiolabeled drug imaging address these challenges and illustrate the promise of applying imaging for optimal development and precision dosing and can be directly applied in pediatric dosing studies. In the presentation we will present an overview of our current knowledge of the association between drug penetration in plasma and target (cancer) cells and their effect on tumor response and discuss approaches for performing measurements of drug uptake at the pharmacological target site in pediatric patients.
Subjects
Paediatrics & NeonatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Pediatrics & Therapeutics.
Conference abstract · 6 Oct 2025
Out of Hospital Neonatal Outcomes (OHNO) registry
Conference abstract · 6 Oct 2025
Innovations in Early Diagnosis of Neonatal Sepsis: Advances in Biomarkers and Clinical Protocols
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPediatrics & Therapeutics
- SubjectPaediatrics & Neonatology
- BylineArticles whose byline prints “Imke H Bartelink”
